(2026). Impact of different PSMA PET-based eligibility criteria on outcome of [Lu]Lu-PSMA radioligand therapy using [F]rhPSMA-7/[F]rhPSMA-7.3 (Flotufolastat). EJNMMI Research.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Impact of Different PSMA PET-based Eligibility Criteria on Outcome of [Lu]Lu-PSMA Radioligand Therapy Using [F]rhPSMA-7/[F]rhPSMA-7.3 (Flotufolastat)."
EJNMMI Research 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Impact of Different PSMA PET-based Eligibility Criteria on Outcome of [Lu]Lu-PSMA Radioligand Therapy Using [F]rhPSMA-7/[F]rhPSMA-7.3 (Flotufolastat)."
EJNMMI Research, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.